coronavirus treatment to the Indian government for eligible hospitalised Covid-19 patients."Lilly is offering donations of Baricitinib to the Indian government through Direct Relief while simultaneously working with local Indian pharmaceutical companies to execute royalty-free voluntary licensing agreements to accelerate the manufacturing and distribution of the medicine in India during the pandemic," the company said in a press release.An initial donation of 400,000 Baricitinib tablets is being made immediately available to the Indian government for eligible hospitalised Covid-19 patients in India and Lilly will work urgently to increase the quantity of donated product multifold over the coming weeks, it added.On Monday, Lilly received.